|
|
|
|
|
|
|
|
|
|
|
11.03.26 - 21:09
|
H.B. Fuller to Report First Quarter 2026 Results on March 25, 2026 (Business Wire)
|
|
|
ST. PAUL, Minn.--(BUSINESS WIRE)--H.B. Fuller Company (NYSE: FUL) announced plans to report its financial results for the three-month fiscal period ended February 28, 2026, in a press release issued after the market close on March 25, 2026. The Company will hold an investor conference call on March 26, 2026, at 9:30 a.m. CT (10:30 a.m. ET) to discuss its financial results.
Interested parties may listen to the conference call on a live webcast. The webcast, along with a supplemental presentation, may be accessed from the company's website at https://investors.hbfuller.com. Participants must register prior to accessing the webcast using this link and should do so at least 10 minutes prior to the start of the call to install and test any necessary software and audio connections. Participants can pre-register for the webcast at any time using the link above. The webcast will be archived on the company's website.
A telephone replay of the conference call will be available from 12:30 p.m. CT on March 26, 2026...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11.03.26 - 14:01
|
Symrise Hold (DPA-AFX)
|
|
|
HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Symrise von 79,25 auf 81,20 Euro angehoben und die Einstufung auf "Hold" belassen. Er habe seine Schätzungen für den Aromen- und Duftstoffehersteller an die Anfang März veröffentlichten, ......
|
|
|
|
|
11.03.26 - 13:42
|
Trading by management and close relations of management (GlobeNewswire EN)
|
|
|
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the “Market Abuse Regulation”) and commission delegated regulation (EU) 1052/2016of 8 March 2016, Novonesis reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B....
|
|
|
|